Eltrombopag and its beneficial role in management of ulcerative Colitis associated with ITP as an upfront therapy case report

Eltrombopag can be used safely as upfront medication in the management of ulcerative colitis as well as ITP, and it showed a beneficial effect in both disorders.

Detalles Bibliográficos
Autores principales: Abdelmahmuod, Elabbass A., Ali, Elrazi, Ahmed, Mohanad A., Yassin, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981772/
https://www.ncbi.nlm.nih.gov/pubmed/33768857
http://dx.doi.org/10.1002/ccr3.3783

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981772/
https://www.ncbi.nlm.nih.gov/pubmed/33768857
http://dx.doi.org/10.1002/ccr3.3783

Ejemplares similares